A medical condition defined by BMI over 30, linked to chronic disease.
The FDA has required warning labels on GLP-1 drugs used for obesity and diabetes after reviewing data that link a rare eye condition, NAION, to these medications. The warning covers a dozen drugs, including Ozempic, Wegovy, Mounjaro and Zepbound. Trials and real-world data show NAION occurrences are rare but higher than in non-GLP-1 therapies.
A wave of studies finds that AI analysis of mammograms can identify cardiovascular risks in women, including hypertension, coronary heart disease and stroke, alongside breast cancer screening. Researchers say mammograms could become a dual-purpose tool for early cardiovascular risk detection, prompting earlier intervention.
A Berlin-led study presented at the ESC Congress finds higher blood levels of xylitol are associated with increased risk of major cardiovascular events. The association is dose-dependent and persists across age and risk factors, prompting calls for further research.
A study from Anglia Ruskin University finds traditional dieting is less effective for men, who view dieting as restrictive and feminine. Partners often support men, while male-focused programmes that emphasize quick wins, social competition and strength may boost engagement. Researchers advocate practical, non-dieting strategies and sport-related challenges.
England expands a seven-minute cholesterol test to 100 pharmacies as part of a national push to spot heart-disease risk early. Patients aged 40-84 without recent tests can get a fingertip cholesterol reading, a blood pressure check, and tailored lifestyle advice. Early detection aims to reduce heart attacks, strokes, and NHS pressure.
A new analysis shows a rise in cancers among people under 50 across England, the US and the Netherlands, driven by obesity, diet and lifestyle factors, with bowel, kidney and uterine cancers among the fastest-growing. Experts urge research and prevention as diagnosis at younger ages becomes more common.